Dupont Capital Management Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Dupont Capital Management Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$23.68 - $38.51 $9,945 - $16,174	-420 Reduced 15.99%	2,206 $56,000
Q4 2022 Jan 26, 2023	SELL	$28.0 - $40.56 $13,496 - $19,549	-482 Reduced 15.51%	2,626 $0
Q3 2022 Oct 31, 2022	SELL	$29.63 - $48.31 $30,874 - $50,339	-1,042 Reduced 25.11%	3,108 $103,000
Q1 2022 Apr 27, 2022	SELL	$39.62 - $69.97 $7,052 - $12,454	-178 Reduced 4.11%	4,150 $191,000
Q4 2021 Jan 31, 2022	SELL	$58.09 - $82.51 $154,693 - $219,724	-2,663 Reduced 38.09%	4,328 $287,000
Q3 2021 Nov 03, 2021	SELL	$58.38 - $84.96 $189,443 - $275,695	-3,245 Reduced 31.7%	6,991 $436,000
Q2 2021 Jul 30, 2021	BUY	$62.15 - $90.32 $40,024 - $58,166	644 Added 6.71%	10,236 $848,000
Q1 2021 Apr 29, 2021	SELL	$61.35 - $90.47 $6,687 - $9,861	-109 Reduced 1.12%	9,592 $636,000
Q4 2020 Jan 28, 2021	SELL	$43.82 - $85.37 $278,213 - $542,014	-6,349 Reduced 39.56%	9,701 $744,000
Q3 2020 Oct 29, 2020	SELL	$33.21 - $51.27 $222,639 - $343,714	-6,704 Reduced 29.46%	16,050 $691,000
Q2 2020 Jul 24, 2020	BUY	$26.12 - $43.27 $249,001 - $412,492	9,533 Added 72.1%	22,754 $983,000
Q1 2020 Apr 29, 2020	SELL	$20.56 - $63.12 $180,886 - $555,329	-8,798 Reduced 39.96%	13,221 $380,000
Q3 2019 Oct 28, 2019	BUY	$26.26 - $34.86 $578,218 - $767,582	22,019 New	22,019 $620,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.